Smart Hospital Project

A prospective multi-centred international study.

Neonatal jaundice is common in the first days of life, and phototherapy has long been a highly effective treatment. Yet, because light exposure is typically checked only periodically, clinicians often lack continuous data on the exact dose each infant receives.

This study introduces an exciting new technology: the Bilisensor: a small, wireless phototherapy dosimeter developed by Wearifi Inc. Designed to measure light intensity continuously within the key therapeutic blue-light range, the device provides real-time insights into each newborn’s phototherapy exposure.

By enabling more precise monitoring, this innovation has the potential to enhance treatment optimization, support clinical decision-making, and further strengthen the safety and effectiveness of phototherapy for newborns.

Neonatal jaundice is common in the first days of life, and phototherapy has long been a highly effective treatment. Yet, because light exposure is typically checked only periodically, clinicians often lack continuous data on the exact dose each infant receives.

This study introduces an exciting new technology: the Bilisensor: a small, wireless phototherapy dosimeter developed by Wearifi Inc. Designed to measure light intensity continuously within the key therapeutic blue-light range, the device provides real-time insights into each newborn’s phototherapy exposure.

By enabling more precise monitoring, this innovation has the potential to enhance treatment optimization, support clinical decision-making, and further strengthen the safety and effectiveness of phototherapy for newborns.

Neonatal jaundice is common in the first days of life, and phototherapy has long been a highly effective treatment. Yet, because light exposure is typically checked only periodically, clinicians often lack continuous data on the exact dose each infant receives.

This study introduces an exciting new technology: the Bilisensor: a small, wireless phototherapy dosimeter developed by Wearifi Inc. Designed to measure light intensity continuously within the key therapeutic blue-light range, the device provides real-time insights into each newborn’s phototherapy exposure.

By enabling more precise monitoring, this innovation has the potential to enhance treatment optimization, support clinical decision-making, and further strengthen the safety and effectiveness of phototherapy for newborns.